To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. If you experience any issues with your products or services, please contact ATCC Customer Service at sales@atcc.org. For Technical questions please contact tech@atcc.org. Thank you.

Privacy Policy Update

We remain dedicated to protecting your data and experience throughout our platforms. We have updated our Privacy Policy and your continued use of the Site means you have accepted the revised Privacy Policy. View now >

SARS-CoV-2 External Control Kit

ATCC quality in a kit—find stability amidst a rapidly changing landscape

Learn more

SARS-CoV-2 Reference Genomes

Download reference-quality sequences for the SARS-CoV-2 Washington state, Italy, Germany, and Hong Kong strains today on the ATCC Genome Portal.

Access high-quality genomes

HIV Reagent Program

We are pleased to announce that ATCC has been awarded a three-year contract by NIAID to manage and operate its HIV Reagent Program.

Get the details

Immuno-oncology Cell Models

Need a model for monitoring immune cell activation? Try our new THP-1 NFAT-Luc2 luciferase reporter cell line!

Get it now

Best Practices for Cell Culture

Having trouble culturing your cells? Watch our on-demand webinar to discover the best practices our experts use at ATCC!

View now

Viral Metagenomics

Don’t let biases in your virome metagenomics workflow confound your results. Watch our on-demand webinar to discover how standards can help.

Watch now

Solutions

Federal

Incredible 2020

Events

Webinars

Therapeutic Development

Human mesenchymal stem cells provide a promising technology for the treatment of acute respiratory distress syndrome, pneumonia, and acute lung injury. Incorporate these cells into your research today!

Vaccine Development

Using CRISPR/Cas9 gene-editing technology, we developed STAT1 knockout cell lines capable of producing high-titer viral stocks. Explore the use of these models in your vaccine research.

Molecular-based Assays

Explore a growing collection of BSL-1 and BSL-2 COVID-19 controls, including a heat-inactivated strain and genomic RNA prepared from the 2019-nCoV/USA-WA1/2020 strain and synthetic SARS-CoV-2 RNA.

FDA/EUA Assay Development

Determine the analytical specificity of your assays by performing cross-reactivity testing with viral, fungal, and bacterial species listed in the FDA EUA. Explore our extensive portfolio.

Primary cells

Choose from our extensive catalog of primary cells from normal and diseased lung tissue. Our collection includes airway epithelial cells, smooth muscle cells, and fibroblasts as well as supporting media and growth kits.

Immune cells

Study the interactions between SARS-CoV-2 and the immune system with human PBMCs, luciferase-labeled monocytes, NK cells, helper T cells, B cells, and cytotoxic T cells from ATCC!

ATCC employee opening a biorepository tank

Biorepository Services^SM

We’ll take care of the logistics and resources needed to keep your COVID-19 materials safe, so you can focus on what’s important—your research.

Custom Controls & Derivatives

We can design and produce external controls and derivatives in a variety of formats to help you verify, validate, and/or routinely monitor the performance of your workflow and assay.

Enhanced Authentication Initiative

ATCC is not only enriching the characterization of our biological collections by using next-generation sequencing, we are also making those data available to everyone through the ATCC Genome Portal.

ATCC Genome Portal

The ATCC Genome Portal makes it easy to find the high-quality whole-genome sequencing data needed for your research. With a free account, you can easily search, download, and analyze hundreds of high-quality genomes.

Exosomes

ATCC offers exosomes derived from well-authenticated cell lines and hTERT-immortalized mesenchymal stem cells. These extracellular vesicles can be used as standards for diagnostics development, disease marker studies, and vaccine development.